Reported by WHO (World Health Organization), around 39 million people worldwide were living with Human Immunodeficiency Viruses (HIV) in 2022. However, despites decades of research, HIV pathogenesis ...

Researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have discovered how a specific type of immune cell may contribute to the persistence of HIV ...

For all that is known about human immunodeficiency virus (HIV), some remarkably fundamental questions remain. One of the most notable, perhaps, is just how HIV manages to infect its primary target, ...

The key obstacle against the cure of human and simian immunodeficiency virus (HIV/SIV) infections is the reservoir of proviruses, which are robustly incorporated into the genomes of host CD4+ T cells.

Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms ...

The FINANCIAL — Bristol-Myers Squibb Company (NYSE:BMY) on February 26 announced data supporting the clinical development of BMS-955176, an investigational component designed to prevent the maturation ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more vulnerable to diseases and infections. Once inside human cells, HIV ...

Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to ...

HIV scientists have long sought to unravel the mysteries of viral latency – a stealthy tactic the virus employs to evade the body's immune defenses. Recent research from the University of North ...